about
Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studiesIntermediate and long-term risk of new-onset heart failure after hospitalization for pneumonia in elderly adults.Oral antibiotic therapy for the treatment of infective endocarditis: a systematic reviewA Retrospective Longitudinal Within-Subject Risk Interval Analysis of Immunoglobulin Treatment for Recurrent Acute Exacerbation of Chronic Obstructive Pulmonary Disease.Endocarditis associated with antineutrophil cytoplasmic antibodies: a case report and review of the literature.Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease.Native valve endocarditis caused by rapidly growing mycobacteria: case report and review of the literature.Role of acute infection in triggering acute coronary syndromes.Immunomodulatory agents in the treatment of community-acquired pneumonia: a systematic review.Acute pneumonia and the cardiovascular system."Inflammation and arterial stiffness in humans".Antimicrobial treatment decision for non-purulent skin and soft tissue infections in the emergency department.Risk stratification for cardiac complications in patients hospitalized for community-acquired pneumonia.Right Heart Function During and After Community-Acquired Pneumonia in Adults.Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality.Pulmonary embolism in patients with acquired immunodeficiency syndrome presenting with clinical picture of Pneumocystis jiroveci pneumonia: report of two cases.The obesity paradox in community-acquired bacterial pneumonia.Chronic obstructive pulmonary disease exacerbation frequency and serum IgG levels.Prevalence of Hypogammaglobulinemia in Adult Invasive Pneumococcal Disease.Coronary artery calcium before and after hospitalization with pneumonia: The MESA study.Study protocol: a randomized, double-blind, parallel, two-arm, placebo control trial investigating the feasibility and safety of immunoglobulin treatment in COPD patients for prevention of frequent recurrent exacerbationsAcute Bacterial Pneumonia is Associated With the Occurrence of Acute Coronary SyndromesAcute Infection and Myocardial InfarctionAzithromycin for Prevention of Exacerbations of COPDTiming of antibiotics and community-acquired pneumoniaStatins and HIV: beyond the metabolic and cardiovascular benefitLocalized Mycobacterium avium complex infection of vertebral and paravertebral structures in an HIV patient on highly active antiretroviral therapyThe association between Staphylococcus aureus bacteremia and acute myocardial infarctionAnemia and community-acquired pneumococcal pneumoniaIncreased levels of platelet microparticles in HIV-infected patients with good response to highly active antiretroviral therapyHospitalization for pneumonia and risk of cardiovascular disease--replyAcute Infection and Myocardial Infarction. Reply
P50
Q28743162-634877DD-162D-49FC-9447-188B45DEE1F5Q34490627-A8431545-69FD-45E5-8138-5D4DEE047229Q35119494-B04FE1B0-331E-4E29-978D-4E7A43536AA4Q35838507-611130CB-539F-4322-87BE-5799FFA4E5CAQ36378933-E8AE8BA3-F597-497E-B23B-A285F894A280Q36394783-B6362ADE-00BF-48B9-AC33-AF2DF66B134CQ36852872-97F71A87-2543-439C-A682-D9CF3DE900E8Q37683958-76F04264-09C0-4606-BBDB-F814C8F7CE7DQ37901715-858E6EBB-4802-43AA-ABD7-B1657E4D4D2AQ38075209-00333784-413D-413E-9323-1327CB4F66F6Q38281043-43C083A5-B95E-4A13-99F2-29A770E1CBE6Q38830691-DFE1F8C8-96E7-4990-856E-0769DD6FD40FQ39280157-A14B3D86-9039-425D-9549-E7BEF54ABFB1Q40093832-D96EC057-E71B-443B-A724-DBD4999C4585Q44077456-2B878345-A67F-4C00-9A31-EB901764D42EQ44132781-17F319A6-F5B8-4535-AD5C-D02101E0A3B5Q44168009-E2934BBE-80BB-4650-BAC1-DCE396F5169DQ49992476-416749A9-2322-4F30-A772-D66A4778C9ACQ50062989-4AA5FDDB-3CCC-4C05-B9A4-86A303FE0A55Q50114657-E0796949-34B3-4641-ADF5-BD930A743AA4Q58788514-29FF28C0-6B37-4083-87C7-061F683EB086Q58883370-9956B163-B9F5-4A32-9258-7E6FE247D63DQ60638681-AC4EEB9F-E4C0-401A-AA25-1298062E0BF8Q61946529-5C7F3B63-418B-4666-AEF9-68E2B23745A6Q80197560-28DD2E17-A6BF-4F0C-B739-F467AA002683Q80358036-32E76708-620F-48B0-89B4-B79B854741E6Q82694032-53149F11-A366-49BF-A0C0-F0406428F0E0Q83735995-03FF2B10-6AA0-4AA4-BFD2-53904422E05FQ84071211-411C0EF7-9832-422E-ABA6-2E787BC195FBQ84307947-AD87713D-5181-4024-A85E-73CDF21CBEC9Q87245961-6A25756B-70D5-415A-9D2E-BD9797CDB4FFQ93002957-D94997AD-1F7B-4968-A9F5-C26CC4C62D6C
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Vicente Corrales-Medina
@ast
Vicente Corrales-Medina
@en
Vicente Corrales-Medina
@es
Vicente Corrales-Medina
@nl
Vicente Corrales-Medina
@sl
type
label
Vicente Corrales-Medina
@ast
Vicente Corrales-Medina
@en
Vicente Corrales-Medina
@es
Vicente Corrales-Medina
@nl
Vicente Corrales-Medina
@sl
prefLabel
Vicente Corrales-Medina
@ast
Vicente Corrales-Medina
@en
Vicente Corrales-Medina
@es
Vicente Corrales-Medina
@nl
Vicente Corrales-Medina
@sl
P106
P21
P31
P496
0000-0002-9691-491X
P569
2000-01-01T00:00:00Z